These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36544158)

  • 1. A doctor-nurse-patient mobile health management system effectively controls blood glucose in chinese patients with type 2 diabetes mellitus: a prospective study.
    Tan X; Qi Z; Chen L; Li D; Cai X; Song Y; Liu Y
    BMC Health Serv Res; 2022 Dec; 22(1):1564. PubMed ID: 36544158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review.
    Pai LW; Chang PY; Chen W; Hwu YJ; Lai CH
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-20. PubMed ID: 27820154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Gregg EW; Cheng YJ; Li G; Bennett PH;
    Diabetes Obes Metab; 2021 Oct; 23(10):2385-2394. PubMed ID: 34212465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial.
    Yang W; Yang Z; Zhao J; Lu H; Luo T
    Trials; 2016 Sep; 17(1):470. PubMed ID: 27669747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Pattern and Factors Associated with Blood Pressure and Fasting Plasma Glucose Control among Patients with Type 2 Diabetes Mellitus in Police Referral Hospital in Ethiopia.
    Shimels T; Abebaw M; Bilal AI; Tesfaye T
    Ethiop J Health Sci; 2018 Jul; 28(4):461-472. PubMed ID: 30607059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.
    Zhang B; Zhao J; Yang W;
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Medical Nutritional Therapy in the Management of Type 2 Diabetes Mellitus.
    Varadaraj G; Sangeetha B; Nithiya DR; Dixit PK
    J Assoc Physicians India; 2021 Apr; 69(4):11-12. PubMed ID: 34470186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes.
    Stringer F; DeJongh J; Enya K; Koumura E; Danhof M; Kaku K
    Diabetes Technol Ther; 2015 Mar; 17(3):215-23. PubMed ID: 25531677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of mHealth management with an implantable glucose sensor and a mobile application among Chinese adults with type 2 diabetes.
    Guo M; Meng F; Guo Q; Bai T; Hong Y; Song F; Ma Y
    J Telemed Telecare; 2023 Sep; 29(8):632-640. PubMed ID: 34152238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of menopausal status on onset of impaired fasting glucose and type 2 diabetes mellitus].
    Wen JB; Yang S; Zhao XH; Chen YC; Zhao HL; Chen XT; Shen C
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):728-733. PubMed ID: 28763923
    [No Abstract]   [Full Text] [Related]  

  • 14. NIDDM: new once-daily intervention for type 2 diabetes mellitus: Diaprel MR.
    Ionescu-Tîrgovişte C; Gavrilă L; Brădescu OM; Guja C
    Rom J Intern Med; 2004; 42(2):431-40. PubMed ID: 15529633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetic patient-centered care.
    Prueksaritanond S; Tubtimtes S; Asavanich K; Tiewtranon V
    J Med Assoc Thai; 2004 Apr; 87(4):345-52. PubMed ID: 15217167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated risk of an intermediate or high SYNTAX score in subjects with impaired fasting glucose.
    Yang X; Liu H; Yang F; Dong P; Fa X; Zhang Q; Li L; Wang Z; Zhao D
    Intern Med; 2015; 54(5):439-44. PubMed ID: 25758067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.
    Mata-Cases M; Mauricio D; Franch-Nadal J
    J Diabetes; 2017 Jan; 9(1):34-44. PubMed ID: 26749415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study.
    Wang X; Wu G; Shen D; Zhang X; Yang W
    Adv Ther; 2022 Jun; 39(6):2820-2830. PubMed ID: 35430674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III).
    Li L; Yang T; Xue Y; Ruan P; Du J; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2022 Jan; 39(1):421-429. PubMed ID: 34757600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between ambient temperature and fasting plasma glucose, temperature-adjusted type 2 diabetes prevalence and control rate: a series of cross-sectional studies in Guangdong Province, China.
    Luo J; He G; Xu Y; Chen Z; Xu X; Peng J; Chen S; Hu J; Ji G; Liu T; Zeng W; Li X; Xiao J; Guo L; He Q; Ma W
    BMC Public Health; 2021 Aug; 21(1):1534. PubMed ID: 34380442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.